Get started
Eli Lilly and CompanyEli Lilly and CompanyEli Lilly and Company

Eli Lilly and Company

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsForecastSeasonalsBondsETFs

LLY chart


Full chart

LLY upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪685.75 B‬ USD
Dividend yield (indicated)
0.83%
Price to earnings Ratio (TTM)
49.14
Basic EPS (TTM)
15.11 USD
Net income (FY)
‪10.59 B‬ USD
Revenue (FY)
‪45.04 B‬ USD
Shares float
‪848.72 M‬
Beta (1Y)
0.63

Employees


Employees (FY)
‪47 K‬
Change (1Y)
‪+4 K‬ +9.30%
Revenue / Employee (1Y)
—
Net income / Employee (1Y)
—

About Eli Lilly and Company


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
David A. Ricks
Website
lilly.com
Headquarters
Indianapolis
Founded
1876
ISIN
US5324571083
FIGI
BBG000BNBDC2
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Check out other big names from the same industry as LLY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

LLY news



Ideas



See all ideas 

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

LLY highest yielding bonds


XS238628644
Eli Lilly and Company 1.625% 14-SEP-2043
Yield to maturity
5.90%
Maturity date
Sep 14, 2043
LLY4099975
Eli Lilly and Company 4.65% 15-JUN-2044
Yield to maturity
5.65%
Maturity date
Jun 15, 2044
LLY6153503
Eli Lilly and Company 5.65% 15-OCT-2065
Yield to maturity
5.47%
Maturity date
Oct 15, 2065
LLY5750032
Eli Lilly and Company 5.1% 09-FEB-2064
Yield to maturity
5.47%
Maturity date
Feb 9, 2064
LLY5871804
Eli Lilly and Company 5.2% 14-AUG-2064
Yield to maturity
5.47%
Maturity date
Aug 14, 2064
LLY5547405
Eli Lilly and Company 4.95% 27-FEB-2063
Yield to maturity
5.47%
Maturity date
Feb 27, 2063
LLY6003397
Eli Lilly and Company 5.6% 12-FEB-2065
Yield to maturity
5.45%
Maturity date
Feb 12, 2065
US532457BU1
Eli Lilly and Company 4.15% 15-MAR-2059
Yield to maturity
5.44%
Maturity date
Mar 15, 2059
US532457BY3
Eli Lilly and Company 2.25% 15-MAY-2050
Yield to maturity
5.42%
Maturity date
May 15, 2050
LLY5750031
Eli Lilly and Company 5.0% 09-FEB-2054
Yield to maturity
5.40%
Maturity date
Feb 9, 2054
LLY6153502
Eli Lilly and Company 5.55% 15-OCT-2055
Yield to maturity
5.39%
Maturity date
Oct 15, 2055

See all LLY bonds 

Sparks


Curated watchlists where LLY is featured.

See all sparks 

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on BOATS exchange Eli Lilly and Company stocks are traded under the ticker LLY.
We've gathered analysts' opinions on Eli Lilly and Company future price: according to them, LLY price has a max estimate of 1,190.00 USD and a min estimate of 700.00 USD. Watch LLY chart and read a more detailed Eli Lilly and Company stock forecast: see what analysts think of Eli Lilly and Company and suggest that you do with its stocks.
LLY reached its all-time high on Jul 15, 2024 with the price of 972.54 USD, and its all-time low was 283.10 USD and was reached on Apr 27, 2022. View more price dynamics on LLY chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Eli Lilly and Company financials in yearly and quarterly reports right on TradingView.
Eli Lilly and Company is going to release the next earnings report on Oct 30, 2025. Keep track of upcoming events with our Earnings Calendar.
LLY earnings for the last quarter are 6.31 USD per share, whereas the estimation was 5.60 USD resulting in a 12.70% surprise. The estimated earnings for the next quarter are 6.36 USD per share. See more details about Eli Lilly and Company earnings.
Eli Lilly and Company revenue for the last quarter amounts to ‪15.56 B‬ USD, despite the estimated figure of ‪14.70 B‬ USD. In the next quarter, revenue is expected to reach ‪16.04 B‬ USD.
LLY net income for the last quarter is ‪5.66 B‬ USD, while the quarter before that showed ‪2.76 B‬ USD of net income which accounts for 105.14% change. Track more Eli Lilly and Company financial stats to get the full picture.
Yes, LLY dividends are paid quarterly. The last dividend per share was 1.50 USD. As of today, Dividend Yield (TTM)% is 0.80%. Tracking Eli Lilly and Company dividends might help you take more informed decisions.
Eli Lilly and Company dividend yield was 0.67% in 2024, and payout ratio reached 44.39%. The year before the numbers were 0.78% and 77.91% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 27, 2025, the company has ‪47 K‬ employees. See our rating of the largest employees — is Eli Lilly and Company on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Eli Lilly and Company EBITDA is ‪24.33 B‬ USD, and current EBITDA margin is 41.75%. See more stats in Eli Lilly and Company financial statements.
Like other stocks, LLY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Eli Lilly and Company stock right from TradingView charts — choose your broker and connect to your account.